SHARON CAM WHITEHORN: Open Payments
NPI 1407100993 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 16 payments from 6 companies in 2025. Trend: 2023 $1,418 · 2024 $325 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $244 |
| GlaxoSmithKline, LLC. | 5 | $107 |
| Optinose US, Inc. | 2 | $52 |
| GENZYME CORPORATION | 1 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: PROPEL, NUCALA, Xhance, DUPIXENT, NUVENT, STEALTHSTATION S8 PLATFORM, NEFFY, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
